Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Attitudes of Croatian pulmonologists concerning obstacles to earlier, more appropriate use of biologics in severe asthma: Survey results (CROSBI ID 322888)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Popović Grle, Sanja ; Lampalo, Marina ; Škrinjarić Cincar, Sanda ; Bulat Kardum, Ljiljana ; Gudelj, Ivan ; Basioli Kasap, Eugenija ; Vergles, Mirna ; Tudorić, Neven Attitudes of Croatian pulmonologists concerning obstacles to earlier, more appropriate use of biologics in severe asthma: Survey results // PLoS One, 16 (2021), 6; e0253468, 14. doi: 10.1371/journal.pone.0253468

Podaci o odgovornosti

Popović Grle, Sanja ; Lampalo, Marina ; Škrinjarić Cincar, Sanda ; Bulat Kardum, Ljiljana ; Gudelj, Ivan ; Basioli Kasap, Eugenija ; Vergles, Mirna ; Tudorić, Neven

engleski

Attitudes of Croatian pulmonologists concerning obstacles to earlier, more appropriate use of biologics in severe asthma: Survey results

Aims Biologics have been proven efficacious for patients with severe asthma (SA). It is essential to diagnose such individuals correctly. This study was designed to survey pulmonologists to identify barriers to early diagnosis and subsequent appropriate use of biologics for SA in Croatia. Methods A pulmonologist group with expertise in SA developed the initial list of questions, with the final questionnaire created according to a 2-round Delphi method. The resulting survey consisted of 23 items consequently divided into 4 domains: 1) Pulmonologists’ demographics and professional experiences ; 2) Concerns about asthma management ; 3) Attitudes toward SA diagnosis ; and 4) Beliefs and attitudes regarding the use of biologics in managing SA. The given answers represented the respondents’ estimates. Results Eighty-four surveys were analyzed, with pulmonologists observing that general practitioners often inaccurately diagnose asthma and treat acute exacerbations. Although specialist centers are capably and correctly equipped, the time to diagnose patients with SA is approximately 3.5 months, with initial use of biologics delayed an additional 2 months. The primary indications for prescribing biologics are conventional therapy with oral glucocorticoids (91.7%) and frequent acute exacerbations (82.1%). In addition to improper diagnosis (64.3%), many patients with SA do not receive the indicated biologics owing to strict administrative directives for reimbursement (70.2%) or limited hospital resources (57.1%). Limitations The limitations of this survey include the subjective nature of the collected data, the relatively small sample size, and the lack of the biologic efficacy evaluation. Conclusions Croatian pulmonologists observed that a significant number of patients with SA who are eligible for biologics are not prescribed them, largely because of an inaccurate and/or delayed diagnosis, a delayed referral to a specialist center, highly restrictive criteria for reimbursement, and/or institutional budgetary limitations.

asthma ; biological products ; Croatia ; female ; health knowledge, attitudes, practice ; humans ; male ; pulmonologists ; referral and consultation

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

16 (6)

2021.

e0253468

14

objavljeno

1932-6203

10.1371/journal.pone.0253468

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost